Finance

>

Latest News

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027

August 1st 2025

Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and continued R&D investments.

Credit: zimmytws | stock.adobe.com. Balancing profitability with affordability, redesigning supply chains for resilience, and engaging actively in trade policy discussions are no longer optional, they are strategic imperatives.
How Can Pharma Leadership Prepare for the Current Tariff Environment and Potential Changes in 2026?

August 1st 2025

Moderna to Reduce Workforce by 10% Amid Cost Restructuring
Moderna to Reduce Workforce by 10% Amid Cost Restructuring

August 1st 2025

Bausch Health Acquires DURECT Corporation in Deal Worth up to $413 Million
Bausch Health Acquires DURECT Corporation in Deal Worth up to $413 Million

July 30th 2025

Bristol Myers Squibb Spins Out Immunology Assets into New Company Backed by Bain Capital
Bristol Myers Squibb Spins Out Immunology Assets into New Company Backed by Bain Capital

July 29th 2025

More News

Site Logo

Finance: Q&A with Annette Grimaldi

March 1st 2007

The latest dealmaking trends: Early-stage is back in favor. There's more money to be made in being acquired than in going public. And license deals are putting more on the back end.

Site Logo

Finance: Promotional Productivity

March 1st 2006

Lovenox still needs a defense strategy to hold share, but it requires less investment as a specialty product. Instead, Lovenox should throw cash over to Acomplia, the putative future star of the Sanofi-Aventis portfolio.

<1
...
678910